Vanguard Group Inc Mirum Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,545,369 shares of MIRM stock, worth $182 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,545,369

Previous 2,564,869 0.76%

Holding current value

$182 Million

Previous $131 Million 42.96%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$48.39 - $77.69 $943,605 - $1.51 Million	-19,500 Reduced 0.76%	2,545,369 $187 Million
Q2 2025 Aug 11, 2025	BUY	$38.39 - $51.11 $952,379 - $1.27 Million	24,808 Added 0.98%	2,564,869 $131 Million
Q1 2025 May 09, 2025	BUY	$41.32 - $53.16 $4.77 Million - $6.13 Million	115,327 Added 4.76%	2,540,061 $114 Million
Q4 2024 Feb 11, 2025	SELL	$37.85 - $46.65 $2.7 Million - $3.33 Million	-71,378 Reduced 2.86%	2,424,734 $100 Million
Q3 2024 Nov 13, 2024	BUY	$33.68 - $44.74 $1.66 Million - $2.21 Million	49,379 Added 2.02%	2,496,112 $97.3 Million
Q2 2024 Aug 13, 2024	BUY	$23.57 - $34.85 $5.54 Million - $8.19 Million	235,048 Added 10.63%	2,446,733 $83.7 Million
Q1 2024 May 10, 2024	SELL	$24.92 - $30.02 $6.59 Million - $7.94 Million	-264,559 Reduced 10.68%	2,211,685 $55.6 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $21.2 Million - $27.3 Million	782,901 Added 46.23%	2,476,244 $73.1 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $2.43 Million - $3.24 Million	98,685 Added 6.19%	1,693,343 $53.5 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $7.54 Million - $9.65 Million	320,831 Added 25.19%	1,594,658 $41.3 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $221,241 - $277,848	11,529 Added 0.91%	1,273,827 $30.6 Million
Q4 2022 Feb 10, 2023	BUY	$17.59 - $23.83 $305,591 - $413,998	17,373 Added 1.4%	1,262,298 $24.6 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $5.23 Million - $7.71 Million	261,950 Added 26.65%	1,244,925 $26.2 Million
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $4.01 Million - $5.99 Million	217,791 Added 28.46%	982,975 $19.1 Million
Q1 2022 May 13, 2022	SELL	$15.5 - $23.93 $669,057 - $1.03 Million	-43,165 Reduced 5.34%	765,184 $16.9 Million
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $961,811 - $1.43 Million	73,702 Added 10.03%	808,349 $12.9 Million
Q3 2021 Nov 12, 2021	BUY	$13.95 - $20.18 $43,942 - $63,567	3,150 Added 0.43%	734,647 $14.6 Million
Q2 2021 Aug 13, 2021	BUY	$15.84 - $20.6 $11.6 Million - $15.1 Million	731,497 New	731,497 $12.6 Million

Others Institutions Holding MIRM

# of Institutions

290

Shares Held

57.7M

Call Options Held

86.1K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Mirum Pharmaceuticals, Inc. Transaction History